RBC Capital Mkts downgrades Caribou Biosciences to Sector Perform
RBC Capital Markets downgraded Caribou Biosciences (CRBU) to a Sector Perform rating and set a $1 price target, from an Outperform rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.